Feb. 08, 2023
Current Trends in Host Cell Protein Detection for Biologics Manufacturing
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Perspectives
-
-
Sep. 09, 2022Dr. Weichang Zhou, CTO of WuXi Biologics: Secure the Future of Bioprocessing -
Sep. 06, 2022Media Insights: How to leverage advancing technologies and enable innovation rapidly and cost-effectively? -
Jul. 06, 2022Media Insights: Dr. Jijie Gu, CSO of WuXi Biologics, Comments on BsAbs R&D Trend -
May. 11, 2022What’s the key to being a leader in the industry? -
Mar. 04, 2022The Watershed Moment for ADCs has Arrived -
Apr. 20, 2020Fierce Pharma Virtual Series – Expert Panel Discussion Featuring Chris Chen -
Aug. 28, 2019New Flexible Bispecific Antibody Format Demonstrates Improved Therapeutic Properties and Manufacturability -
Apr. 11, 2019Biologic Products DNA to IND Timeline in 9 Months – Yes it can be done!
Notice:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?